Lirum Therapeutics Presents Data on LX-101, a Novel Clinical-Stage Targeted Therapy, Demonstrating Potent Preclinical Activity Against a Range of Pediatric Cancers
NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) — Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage…
AI Has No Single Answer About Your Brand: Why 43% of AI Answers Swap Leading Banks and Single Visibility Scores Fail Banking Leaders
TransNusa Celebrates Historic Milestone With Launch Off Maiden Melbourne-Bali Flight
Scalare Expands National Ecosystem with Brisbane Workspace, New Investment in Auric and Equityroom Launch
CropLife Asia Welcomes New BASF, Corteva and FMC Representatives to Board
Extension of Lock-up by Management Aligns with Long-Term Growth, Yunji Technology Continues Business Expansion During Nine Months